Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases. A randomized controlled trial

JAMA

Volumn 280, Issue 13, 1998, Pages 1161-1167

  Kamb, Mary L ^a   Fishbein, Martin ^a   Douglas, John M ^b   Rhodes, Fen ^d   Rogers, Judy ^e   Bolan, Gail ^f   Zenilman, Jonathan ^g   Hoxworth, Tamara ^c   Malotte, C Kevin ^d   Iatesta, Michael ^e   Kent, Charlotte ^f   Lentz, Andrew ^g   Graziano, Sandra ^a   Byers, Robert H ^a   Peterman, Thomas A ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b DENVER PUBLIC HEALTH   (United States)

^c Colorado Dept of Hlth and Environ ^*

^d CALIFORNIA STATE UNIVERSITY   (United States)

^e Newark STD Clinic   (United States)

^f San Francisco Department of Health   (United States)

^g JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HEALTH BEHAVIOR; HEALTH EDUCATION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; PATIENT COUNSELING; PATIENT EDUCATION; PRIORITY JOURNAL; RISK ASSESSMENT; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; VIRUS TRANSMISSION;

EID: 0032494396     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.280.13.1161     Document Type: Article

References (30)

1. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report. Atlanta, Ga: Centers for Disease Control and Prevention; 1997:861-867. Report 46.
2. Centers for Disease Control and Prevention. Update: mortality attributable to HIV infection among persons aged 25-44 years - United States, 1996. MMWR Morb Mortal Wkly Rep. 1996;45:121-125.
3. Weinstock HS, Sidhu J, Gwinn M, Karon J, Petersen LR. Trends in HIV seroprevalence among persons attending sexually transmitted disease clinics in the United States, 1988-1992. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;9:514-522.
4. Holtgrave DR, Pinkerton SD. Updates of cost of illness and quality of life estimates for use in economic evaluations of HIV prevention programs. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;16:54-62. (In press-anticipated date is April 1998).
5. Oakley A, Fullerton D, Holland J. Behavioural interventions for HIV/AIDS prevention. AIDS. 1995;9:479-486.
6. Peterman TA, Aral SO. Evaluating behavioral interventions. JAMA. 1993;269:2845.
7. Grosskurth H, Mosha F, Todd J, et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomized controlled trial. Lancet. 1995;346:530-536.
8. Higgins DL, Galavotti C, O'Reilly KR, et al. Evidence for the effects of HIV antibody counseling and testing on risk behaviors. JAMA. 1991;226:2419-2429.
9. Wolistky RJ, MacGowan JR, Higgins DL, Jorgensen CM. The effects of HIV counseling and testing on risk-related practices and help-seeking behavior. AIDS Educ Prev. 1997;9(suppl 3):52-67.
10. Kamb ML, Dillon B, Fishbein M, Willis KL, Project RESPECT Study Group. Quality assurance of HIV prevention counseling in a multi-center randomized controlled trial. Public Health Rep. 1996; 111(ssuppl 1):99-107.
11. Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity. J Stud Alcohol. 1997;58:7-29.
12. Rotheram-Borus MJ, Koopman C, Haignere C, et al. Reducing HIV risk behaviors among runaway adolescents. JAMA. 1991;266:1237-1241.
13. Schulz KF. Subverting randomization in controlled trials. JAMA. 1995;274:1456-1458.
14. Ajzen I, Fishbein M. Understanding Attitudes and Predicting Behavior. Englewood Cliffs, NJ: Prentice Hall; 1980.
15. Fishbein M, Bandura A, Triandis HC, et al. Factors Influencing Behavior and Behavior Change: Final Report - Theorist's Workshop. Rockville, MD: National Institute of Mental Health; 1992.
16. Fishbein M, Middlestadt SE, Hitchcock PJ. Using information to change sexually transmitted disease-related behaviors. In: Wasserheit JN, Aral SO, Holmes KK, eds. Research Issues in Human Behavior and Sexually Transmitted Diseases in the AIDS Era. Washington, DC: American Society for Microbiology; 1991:243-257.
17. Centers for Disease Control and Prevention. HIV Counseling, Testing, and Referral Standards and Guidelines. Atlanta, Ga: US Dept of Health and Human Services, Centers for Disease Control and Prevention; 1994.
18. Centers for Disease Control and Prevention. Technical guidance on HIV counseling. MMWR Morb Mortal Wkly Rep. 1993;42:11-17.
19. Centers for Disease Control and Prevention. 1993 Sexually transmitted diseases treatment guidelines. MMWR Morb Mortal Wkly Rep. 1993;42(RR-14):1-102.
20. Richeart CA, Peterman TA, Zaidi AA, Ransom RL, Wroten JE, Witte JJ. A method for identifying persons at high risk for sexually transmitted infections. Am J Public Health. 1993;83:520-524.
21. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995;273: 408-412.
22. Zeiger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;42:121-130.
23. Kelly JA, St Lawrence JS, Hood HV, Brasfield TL. Behavioral intervention to reduce AIDS risk activities. J Consult Clin Psychol. 1989;57:60-67.
24. DiClemente RJ, Wingood GM. A randomized controlled trial of an HIV sexual risk-reduction intervention for young African-American women. JAMA. 1995;274:1271-1276.
25. Wasserheit JN. Epidemiologic synergy: interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis. 1992;19:61-77.
26. Rhodes F, Malotte CK. HIV risk interventions for active drug users. In: Oskamp S, Thompson SC, eds. Understanding and Preventing HIV Risk Behavior: Safer Sex and Drug Use. Thousand Oaks, Calif: Sage Publications Inc; 1996:211-214.
27. Standards of Reporting Trial Groups. A proposal for structured reporting of randomized controlled trials. JAMA. 1994; 272:1926-1931.
28. Lawrence J, Kamb ML, Iatesta M, et al, and the Project RESPECT Study Group. Additional sources of care for STD clinic patients. In: Program and abstracts of the 11th International Conference on AIDS; July 7-12, 1996; Vancouver, British Columbia.
29. Flemming TR, DeMets DL. Surrogate end-points in clinical trials: are we being misled? Ann Intern Med. 1996;125:605-613.
30. Centers for Disease Control and Prevention. HIV Counseling and Testing in Publicly Funded Sites: 1995 Summary Report. Atlanta, Ga: US Dept of Health and Human Services, Centers for Disease Control and Prevention; September 1997.